靶向抑制GLUT1对糖尿病视网膜病变中视锥细胞的保护作用

石珂; 赵璐; 杨玉兰; 王盈盈; 汪昌运

您当前的位置：

首页 >

文章列表页 >

靶向抑制GLUT1对糖尿病视网膜病变中视锥细胞的保护作用

论著 | 更新时间：2026-01-09

- 靶向抑制GLUT1对糖尿病视网膜病变中视锥细胞的保护作用
- Target inhibition of glucose transport-1 protects cone photoreceptors in diabetic retinopathy mice
- 陆军军医大学学报 2014年36卷第15期页码：1582-1586
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R339.146;R342;R774.13
- 纸质出版：2014
- 稿件说明：
移动端阅览
石珂,赵璐,杨玉兰,王盈盈,汪昌运.靶向抑制GLUT1对糖尿病视网膜病变中视锥细胞的保护作用[J].陆军军医大学学报(原第三军医大学学报),2014,36(15):1582-1586.

　Shi Ke,Zhao Lu,Yang Yulan,Wang Yingying,Wang Changyun.Target inhibition of glucose transport-1 protects cone photoreceptors in diabetic retinopathy mice[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(15):1582-1586.
石珂,赵璐,杨玉兰,王盈盈,汪昌运.靶向抑制GLUT1对糖尿病视网膜病变中视锥细胞的保护作用[J].陆军军医大学学报(原第三军医大学学报),2014,36(15):1582-1586. DOI：

　Shi Ke,Zhao Lu,Yang Yulan,Wang Yingying,Wang Changyun.Target inhibition of glucose transport-1 protects cone photoreceptors in diabetic retinopathy mice[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(15):1582-1586. DOI：

摘要

目的观察抑制视网膜上葡萄糖转运蛋白-1（glucose transporter-1

GLUT1）对糖尿病视网膜病变中视锥细胞的影响。方法 27只8周龄C57BL/6小鼠按随机数字表法分为正常对照组、糖尿病对照组和GLUT1小干扰核糖核酸（siRNA）治疗组。腹腔注射链脲佐菌素建立糖尿病模型后，GLUT1 siRNA治疗组予以玻璃体腔注射靶向GLUT1的siRNA，正常对照组和糖尿病对照组注射等量非靶向性siRNA，以上操作每2周重复注射1次，共注射9次。建模第18周3组小鼠行明适应视网膜电图检查视锥细胞功能，免疫荧光共定位法和免疫印迹法检查视网膜GLUT1的表达，测定比较视网膜含糖量，通过免疫荧光共定位法检查视锥细胞的密度及形态改变。结果与糖尿病对照组相比，GLUT1 siRNA治疗组小鼠视网膜GLUT1表达明显下调，较正常对照组下降68.51%（

0.01）。尽管糖尿病对照组和GLUT1 siRNA治疗组视网膜组织含糖量均高于正常对照组，但GLUT1 siRNA治疗组小鼠视网膜含糖量比糖尿病对照组低42.67%，差异有统计学意义（

0.01）；糖尿病对照组和GLUT1 siRNA治疗组小鼠的明适应视网膜电图的a波及b波振幅均低于正常对照组，但GLUT1 siRNA治疗组较糖尿病对照组分别高47.59%和42.61%，差异有统计学意义（

0.01）；形态学检查发现糖尿病对照组较GLUT1 siRNA组视锥细胞排列稀疏，外节形态更为短小。结论 GLUT1 siRNA通过抑制GLUT1表达，限制转运葡萄糖进入视网膜，降低视网膜局部含糖量从而对光感受器视锥细胞产生保护作用。

Abstract

Objective To determine the effect of glucose transporter-1(GLUT1) suppression on cone photoreceptors in diabetic retinopathy in mice. Methods Twenty-seven 8-week-old C57BL/6 mice were divided into normal control

diabetic control and GLUT1 siRNA treatment group. Diabetic model was established by intraperitoneal inj

ection of streptozotocin. GLUT1 siRNA treatment group received intravitreal injection of siRNA-mediated GLUT1

and the other 2 groups received equal amount of non-specific siRNA. The intravitreal injection procedure was repeated every 2 weeks for 9 times in all. In 18 weeks after diabetic induction

photopic electroretinography (ERG) was performed to evaluate cone photoreceptors function

and immunofluorescence assay and Western blotting were carried out to examine the expression of GLUT1. The glucose concentration was determined in the retina. Immunofluorescence colocalization was employed to determine the density and morphological change of cone photoreceptors. Results The expression of GLUT1 was notably down-regulated in GLUT1 siRNA treatment group than diabetic control group

and was lower by 68.51% compared with normal control groups (

0.01). Retinal glucose concentration was obviously higher in the diabetic control and GLUT1 siRNA treatment group than the normal control

but GLUT1 siRNA treatment group was decreased by 42.67% compared with diabetic control（

0.01）. A-wave and b-wave amplitudes in photopic ERG were lower in diabetic control and GLUT1 siRNA treatment group than the normal control

but GLUT1 siRNA treatment group was increased by 47.59%（

0.01）and 42.61%（

0.01）compared with diabetic control

respectively. Morphology examination showed that density of cones were decreased significantly and had a shorten outer-segment appearance in diabetic control group. Conclusion GLUT1 siRNA controls the glucose transport into the retina by suppressing the expression of GLUT1

reduces the glucose concentration in retinal environment

and thus protects cone photoreceptors in diabetic retinopathy.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

糖尿病视网膜病变患者干眼发生率及原因探讨

合并糖尿病白内障患者术后黄斑厚度变化的临床研究

高糖对视网膜色素上皮细胞Toll样受体2表达的影响

糖尿病仓鼠视网膜p38MAPK和TGFβ₂的表达